Skip to main content
Top
Published in: Current Hypertension Reports 5/2012

01-10-2012 | Antihypertensive Therapy: Patient Selection and Special Problems (K Kario and H Rakugi, Section Editors)

Characteristics of Hypertension in the Chinese Population

Authors: Ji-Guang Wang, Yan Li

Published in: Current Hypertension Reports | Issue 5/2012

Login to get access

Abstract

In China, the prevalence of hypertension is currently 18.8 %, and a major risk factor for hypertension is unbalanced dietary sodium and potassium intakes. High dietary sodium intake may change the circadian rhythm of 24-h blood pressure, which is characterized by a higher nighttime blood pressure. The prevalence of isolated nighttime hypertension, defined as a nighttime blood pressure of at least 120 mm Hg systolic or 70 mm Hg diastolic and a daytime systolic/diastolic blood pressure less than 135/85 mm Hg, is higher in Chinese than in Europeans. The complications of hypertension are also different across ethnicities, being mainly stroke instead of myocardial infarction in Chinese. Lowering of blood pressure provides more protection against stroke than against myocardial infarction, and calcium channel blockers provide more protection against stroke than do other classes of antihypertensive drugs. Current Chinese hypertension guidelines recommend calcium channel blockers as the most suitable class of drugs of the five classes of antihypertensive drugs.
Literature
1.
go back to reference Staessen JA, Wang JG, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361:1629–41.PubMedCrossRef Staessen JA, Wang JG, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361:1629–41.PubMedCrossRef
2.
go back to reference Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol. 1995;52:39–44.PubMedCrossRef Wu X, Duan X, Gu D, Hao J, Tao S, Fan D. Prevalence of hypertension and its trends in Chinese populations. Int J Cardiol. 1995;52:39–44.PubMedCrossRef
3.
go back to reference Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, Ma GS, Yang XG, the Technical Working Group of China National Nutrition and Health Survey. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol. 2005;26:478–84. Chinese. Li LM, Rao KQ, Kong LZ, Yao CH, Xiang HD, Zhai FY, Ma GS, Yang XG, the Technical Working Group of China National Nutrition and Health Survey. A description on the Chinese national nutrition and health survey in 2002. Chin J Epidemiol. 2005;26:478–84. Chinese.
4.
go back to reference Li Y, Staessen JA, Li LH, Gao PJ, Thijs L, Zhu DL, Wang JG. Blood pressure and urinary sodium excretion in relation to the A-1984 G adrenomedullin polymorphism in a Chinese population. Kidney Int. 2006;69:1153–8.PubMedCrossRef Li Y, Staessen JA, Li LH, Gao PJ, Thijs L, Zhu DL, Wang JG. Blood pressure and urinary sodium excretion in relation to the A-1984 G adrenomedullin polymorphism in a Chinese population. Kidney Int. 2006;69:1153–8.PubMedCrossRef
5.
go back to reference Wang JG, Liu LF, Zagato L, Xie JX, Fagard R, Jin KG, Wang JX, Li Y, Bianchi G, Staessen JA, Liu LS. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens. 2004;22:937–44.PubMedCrossRef Wang JG, Liu LF, Zagato L, Xie JX, Fagard R, Jin KG, Wang JX, Li Y, Bianchi G, Staessen JA, Liu LS. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens. 2004;22:937–44.PubMedCrossRef
6.
go back to reference Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q, Elliott P, INTERMAP Research Group. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens. 2003;17:623–30.PubMedCrossRef Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q, Elliott P, INTERMAP Research Group. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP study. J Hum Hypertens. 2003;17:623–30.PubMedCrossRef
7.
go back to reference • Liu L, Wang JG, Ma SP, Wang W, Lu FH, Zhang LQ, Banya W, Peters R, Beckett N, Fletcher A, Bulpitt CJ. Chinese subjects entered in the Hypertension in the Very Elderly Trial (HYVET). Chin Med J. 2008;121:1509–12. In hypertensive patients over 80 years of age, Chinese had significantly lower serum potassium concentration than other patient populations. This phenomenon might reflect lower dietary intakes of potassium in Chinese.PubMed • Liu L, Wang JG, Ma SP, Wang W, Lu FH, Zhang LQ, Banya W, Peters R, Beckett N, Fletcher A, Bulpitt CJ. Chinese subjects entered in the Hypertension in the Very Elderly Trial (HYVET). Chin Med J. 2008;121:1509–12. In hypertensive patients over 80 years of age, Chinese had significantly lower serum potassium concentration than other patient populations. This phenomenon might reflect lower dietary intakes of potassium in Chinese.PubMed
8.
go back to reference Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med. 1998;158:741–51.PubMedCrossRef Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med. 1998;158:741–51.PubMedCrossRef
9.
go back to reference Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension. 2000;35:1025–30.PubMedCrossRef Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension. 2000;35:1025–30.PubMedCrossRef
10.
go back to reference ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–97.CrossRef ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–97.CrossRef
11.
go back to reference Guyton AC. Blood pressure control–special role of the kidneys and body fluids. Science. 1991;252:1813–6.PubMedCrossRef Guyton AC. Blood pressure control–special role of the kidneys and body fluids. Science. 1991;252:1813–6.PubMedCrossRef
12.
go back to reference Li Y, Wang JG, Gao PJ, Guo HF, Nawrot T, Wang GL, Qian YS, Staessen JA, Zhu DL. Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study. Blood Press Monit. 2005;10:125–34.PubMedCrossRef Li Y, Wang JG, Gao PJ, Guo HF, Nawrot T, Wang GL, Qian YS, Staessen JA, Zhu DL. Are published characteristics of the ambulatory blood pressure generalizable to rural Chinese? The JingNing population study. Blood Press Monit. 2005;10:125–34.PubMedCrossRef
13.
go back to reference Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension. 2007;50:333–9.PubMedCrossRef Li Y, Staessen JA, Lu L, Li LH, Wang GL, Wang JG. Is isolated nocturnal hypertension a novel clinical entity? Findings from a Chinese population study. Hypertension. 2007;50:333–9.PubMedCrossRef
14.
go back to reference Li LH, Li Y, Huang QF, Sheng CS, Staessen JA, Wang JG. Isolated nocturnal hypertension and arterial stiffness in a Chinese population. Blood Press Monit. 2008;13:157–9.PubMedCrossRef Li LH, Li Y, Huang QF, Sheng CS, Staessen JA, Wang JG. Isolated nocturnal hypertension and arterial stiffness in a Chinese population. Blood Press Monit. 2008;13:157–9.PubMedCrossRef
15.
go back to reference •• Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O’Brien E, Wang J, Staessen JA, on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic value of isolated nocturnal hypertension in 8711 subjects from 10 populations. J Hypertens. 2010;28:2036–45. In an international collaboration of prospective population studies on ambulatory blood pressure monitoring, the prevalence of isolated nocturnal hypertension was higher in East Asians than in eastern and western Europeans. Isolated nocturnal hypertension was associated with unfavorable cardiovascular health outcomes.PubMed •• Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O’Brien E, Wang J, Staessen JA, on behalf of the International Database on Ambulatory blood pressure in relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic value of isolated nocturnal hypertension in 8711 subjects from 10 populations. J Hypertens. 2010;28:2036–45. In an international collaboration of prospective population studies on ambulatory blood pressure monitoring, the prevalence of isolated nocturnal hypertension was higher in East Asians than in eastern and western Europeans. Isolated nocturnal hypertension was associated with unfavorable cardiovascular health outcomes.PubMed
16.
go back to reference Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.CrossRef Asia Pacific Cohort Studies Collaboration. Blood pressure and cardiovascular disease in the Asia Pacific region. J Hypertens. 2003;21:707–16.CrossRef
17.
go back to reference He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027–34.PubMedCrossRef He J, Ogden LG, Vupputuri S, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027–34.PubMedCrossRef
18.
go back to reference Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang JG, Sandoya E, O’Brien E, Staessen JA, on behalf of the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic accuracy of the day versus night ambulatory blood pressure revisited in 7458 randomly recruited subjects. Lancet. 2007;370:1219–29.PubMedCrossRef Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K, Richart T, Ohkubo T, Kuznetsova T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Wang JG, Sandoya E, O’Brien E, Staessen JA, on behalf of the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes (IDACO) Investigators. Prognostic accuracy of the day versus night ambulatory blood pressure revisited in 7458 randomly recruited subjects. Lancet. 2007;370:1219–29.PubMedCrossRef
19.
go back to reference Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130–5. Kario K, Matsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension. 1996;27:130–5.
20.
go back to reference Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852–7. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852–7.
21.
go back to reference Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens. 1998;16:1823–9.PubMedCrossRef Liu L, Wang JG, Gong L, Liu G, Staessen JA, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Comparison of active treatment and placebo for older Chinese patients with isolated systolic hypertension. J Hypertens. 1998;16:1823–9.PubMedCrossRef
22.
go back to reference Wang JG, Staessen JA, Gong L, Liu L, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med. 2000;160:211–20.PubMedCrossRef Wang JG, Staessen JA, Gong L, Liu L, for the Systolic Hypertension in China (Syst-China) Collaborative Group. Chinese trial on isolated systolic hypertension in the elderly. Arch Intern Med. 2000;160:211–20.PubMedCrossRef
23.
go back to reference Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Pagé V, Ghadirian P, LeLorier J, Hamet P. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 1996;14:1237–45.PubMedCrossRef Gong L, Zhang W, Zhu Y, Zhu J, Kong D, Pagé V, Ghadirian P, LeLorier J, Hamet P. Shanghai trial of nifedipine in the elderly (STONE). J Hypertens. 1996;14:1237–45.PubMedCrossRef
24.
go back to reference Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens. 2005;23:2157–72.PubMedCrossRef Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, FEVER Study Group. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens. 2005;23:2157–72.PubMedCrossRef
25.
go back to reference •• Wang JG, Kario K, Lau T, Wei YK, Park CG, Kim CH, Huang J, Zhang WZ, Li Y, Yan P, Hu D. Use of the dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement of the Asian Pacific Heart Association. Hypertens Res. 2011;34:423–30. In this scientific statement, clinical studies on the management of hypertension in East Asians were comprehensively reviewed and discussed with the focus on dihydropyridine calcium channel blockers. In East Asians, calcium channel blockers are more efficacious than other classes of antihypertensive drugs in lowering blood pressure.PubMedCrossRef •• Wang JG, Kario K, Lau T, Wei YK, Park CG, Kim CH, Huang J, Zhang WZ, Li Y, Yan P, Hu D. Use of the dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians: a scientific statement of the Asian Pacific Heart Association. Hypertens Res. 2011;34:423–30. In this scientific statement, clinical studies on the management of hypertension in East Asians were comprehensively reviewed and discussed with the focus on dihydropyridine calcium channel blockers. In East Asians, calcium channel blockers are more efficacious than other classes of antihypertensive drugs in lowering blood pressure.PubMedCrossRef
26.
go back to reference Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.PubMedCrossRef Staessen JA, Wang JG, Thijs L. Cardiovascular prevention and blood pressure reduction: a meta-analysis. Lancet. 2001;358:1305–15.PubMedCrossRef
27.
go back to reference Wang JG, Li Y, Franklin S, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension. 2007;50:181–8.PubMedCrossRef Wang JG, Li Y, Franklin S, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension. 2007;50:181–8.PubMedCrossRef
28.
go back to reference Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000;101:1102–8.PubMedCrossRef Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, Cianflone D, Sanna T, Sasayama S, Maseri A. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000;101:1102–8.PubMedCrossRef
29.
go back to reference Sueda S, Kohno H, Fukuda H, Uraoka T. Did the widespread use of long-acting calcium antagonists decrease the occurrence of variant angina ? Chest. 2003;124:2074–8.PubMedCrossRef Sueda S, Kohno H, Fukuda H, Uraoka T. Did the widespread use of long-acting calcium antagonists decrease the occurrence of variant angina ? Chest. 2003;124:2074–8.PubMedCrossRef
30.
go back to reference Wang JG, Liu M. Utilization of genetic information for the dissection of complex diseases or traits. Hypertens Res. 2011;34:1255–6.PubMedCrossRef Wang JG, Liu M. Utilization of genetic information for the dissection of complex diseases or traits. Hypertens Res. 2011;34:1255–6.PubMedCrossRef
Metadata
Title
Characteristics of Hypertension in the Chinese Population
Authors
Ji-Guang Wang
Yan Li
Publication date
01-10-2012
Publisher
Current Science Inc.
Published in
Current Hypertension Reports / Issue 5/2012
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-012-0288-1

Other articles of this Issue 5/2012

Current Hypertension Reports 5/2012 Go to the issue

Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

Perioperative Hypertension: Defining At-Risk Patients and Their Management

Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

Blood Pressure Variability, Cardiovascular Risk, and Risk for Renal Disease Progression

Antihypertensive Therapy: Patient Selection and Special Problems (K Kario and H Rakugi, Section Editors)

Targeting Hypertension in Patients with Cardiorenal Metabolic Syndrome

Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

Thiazide and Thiazide-like Diuretics: An Opportunity to Reduce Blood Pressure in Patients with Advanced Kidney Disease

Antihypertensive Therapy: Renal Injury (MR Weir and GL Bakris, Section Editors)

Sleep, Slow-Wave Sleep, and Blood Pressure

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.